Literature DB >> 20808234

High-relaxivity magnetic resonance imaging contrast agents. Part 2. Optimization of inner- and second-sphere relaxivity.

Vincent Jacques1, Stéphane Dumas, Wei-Chuan Sun, Jeffrey S Troughton, Matthew T Greenfield, Peter Caravan.   

Abstract

RATIONALE AND
OBJECTIVES: The observed relaxivity of gadolinium-based contrast agents has contributions from the water molecule(s) that bind directly to the gadolinium ion (inner-sphere water), long-lived water molecules and exchangeable protons that make up the second-sphere of coordination, and water molecules that diffuse near the contrast agent (outer-sphere). Inner- and second-sphere relaxivity can both be increased by optimization of the lifetimes of the water molecules and protons in these coordination spheres, the rotational motion of the complex, and the electronic relaxation of the gadolinium ion. We sought to identify new high-relaxivity contrast agents by systematically varying the donor atoms that bind directly to gadolinium to increase inner-sphere relaxivity and concurrently including substituents that influence the second-sphere relaxivity.
METHODS: Twenty gadolinium-1,4,7,10-tetraazacyclo-dodecane-N,N',N″,N'″-tetraacetato derivatives were prepared and their relaxivity determined in presence and absence of human serum albumin as a function of temperature and magnetic field. Data was analyzed to extract the underlying molecular parameters influencing relaxivity. Each compound had a common albumin-binding group and an inner-sphere donor set comprising the 4 tertiary amine N atoms from cyclen, an α-substituted acetate oxygen atom, 2 amide oxygen atoms, an inner-sphere water oxygen atom, and a variable donor group. Each amide nitrogen was substituted with different groups to promote hydrogen bonding with second-sphere water molecules.
RESULTS: Relativities at 0.47 and 1.4 T, 37°C, in serum albumin ranged from 16.0 to 58.1 mM(-1)s(-1) and from 12.3 to 34.8 mM(-1)s(-1), respectively. The reduction of inner-sphere water exchange typical of amide donor groups could be offset by incorporating a phosphonate or phenolate oxygen atom donor in the first coordination sphere, resulting in higher relaxivity. Amide nitrogen substitution with pendant phosphonate or carboxylate groups increased relaxivity by as much as 88% compared with the N-methyl amide analog. Second-sphere relaxivity contributed as much as 24 and 14 mM(-1)s(-1) at 0.47 and 1.4 T, respectively.
CONCLUSIONS: Water/proton exchange dynamics in the inner- and second-coordination sphere can be predictably tuned by choice of donor atoms and second-sphere substituents, resulting in high-relaxivity agents.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20808234      PMCID: PMC3024144          DOI: 10.1097/RLI.0b013e3181ee6a49

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  51 in total

1.  High relaxivity confined to a small molecular space: a metallostar-based, potential MRI contrast agent.

Authors:  João Bruno Livramento; Eva Tóth; Angélique Sour; Alain Borel; André E Merbach; Robert Ruloff
Journal:  Angew Chem Int Ed Engl       Date:  2005-02-25       Impact factor: 15.336

2.  The lanthanide cations as probes in biological systems. Proton relaxation enhancement studies for model systems and lysozyme.

Authors:  R A Dwek; R E Richards; K G Morallee; E Nieboer; R J Williams; A V Xavier
Journal:  Eur J Biochem       Date:  1971-07-29

3.  In vivo evaluation of a new magnetic resonance imaging contrast agent (P947) to target matrix metalloproteinases in expanding experimental abdominal aortic aneurysms.

Authors:  Romain Bazeli; Michèle Coutard; Benjamin Daumas Duport; Eric Lancelot; Claire Corot; Jean-Pierre Laissy; Didier Letourneur; Jean-Baptiste Michel; Jean-Michel Serfaty
Journal:  Invest Radiol       Date:  2010-10       Impact factor: 6.016

4.  Molecular dynamics simulations of MRI-relevant GdIII chelates: direct access to outer-sphere relaxivity.

Authors:  A Borel; L Helm; A E Merbach
Journal:  Chemistry       Date:  2001-02-02       Impact factor: 5.236

5.  Lanthanide(III) complexes of a mono(methylphosphonate) analogue of H4dota: the influence of protonation of the phosphonate moiety on the TSAP/SAP isomer ratio and the water exchange rate.

Authors:  Jakub Rudovský; Petr Cígler; Jan Kotek; Petr Hermann; Pavel Vojtísek; Ivan Lukes; Joop A Peters; Luce Vander Elst; Robert N Muller
Journal:  Chemistry       Date:  2005-04-08       Impact factor: 5.236

6.  A high-frequency EPR study of frozen solutions of Gd(III) complexes: straightforward determination of the zero-field splitting parameters and simulation of the NMRD profiles.

Authors:  Meriem Benmelouka; Johan Van Tol; Alain Borel; Marc Port; Lothar Helm; Louis Claude Brunel; André E Merbach
Journal:  J Am Chem Soc       Date:  2006-06-21       Impact factor: 15.419

7.  High relaxivity magnetic resonance imaging contrast agents. Part 1. Impact of single donor atom substitution on relaxivity of serum albumin-bound gadolinium complexes.

Authors:  Stéphane Dumas; Vincent Jacques; Wei-Chuan Sun; Jeffrey S Troughton; Joel T Welch; Jaclyn M Chasse; Heribert Schmitt-Willich; Peter Caravan
Journal:  Invest Radiol       Date:  2010-10       Impact factor: 6.016

8.  Gadolinium-based magnetic resonance contrast agents at 7 Tesla: in vitro T1 relaxivities in human blood plasma.

Authors:  Iris M Noebauer-Huhmann; Pavol Szomolanyi; Vladimír Juras; Oliver Kraff; Mark E Ladd; Siegfried Trattnig
Journal:  Invest Radiol       Date:  2010-09       Impact factor: 6.016

9.  Synthesis and evaluation of a high relaxivity manganese(II)-based MRI contrast agent.

Authors:  Jeffrey S Troughton; Matthew T Greenfield; Jaclyn M Greenwood; Stéphane Dumas; Andrea J Wiethoff; Jufeng Wang; Marga Spiller; Thomas J McMurry; Peter Caravan
Journal:  Inorg Chem       Date:  2004-10-04       Impact factor: 5.165

10.  Thrombus imaging with fibrin-specific gadolinium-based MR contrast agent EP-2104R: results of a phase II clinical study of feasibility.

Authors:  Josef Vymazal; Elmar Spuentrup; Gerardo Cardenas-Molina; Andrea J Wiethoff; Michael G Hartmann; Peter Caravan; Edward C Parsons
Journal:  Invest Radiol       Date:  2009-11       Impact factor: 6.016

View more
  34 in total

1.  Multifunctional Liposomes for Image-Guided Intratumoral Chemo-Phototherapy.

Authors:  Dyego Miranda; Kevin Carter; Dandan Luo; Shuai Shao; Jumin Geng; Changning Li; Upendra Chitgupi; Steven G Turowski; Nasi Li; G Ekin Atilla-Gokcumen; Joseph A Spernyak; Jonathan F Lovell
Journal:  Adv Healthc Mater       Date:  2017-05-15       Impact factor: 9.933

2.  Structure - relaxivity relationships among targeted MR contrast agents.

Authors:  Peter Caravan; Zhaoda Zhang
Journal:  Eur J Inorg Chem       Date:  2012-04       Impact factor: 2.524

3.  Contrast agents for MRI: 30+ years and where are we going?

Authors:  Valérie C Pierre; Matthew J Allen; Peter Caravan
Journal:  J Biol Inorg Chem       Date:  2014-01-11       Impact factor: 3.358

4.  Comparison of the Relaxivities of Macrocyclic Gadolinium-Based Contrast Agents in Human Plasma at 1.5, 3, and 7 T, and Blood at 3 T.

Authors:  Pavol Szomolanyi; Martin Rohrer; Thomas Frenzel; Iris M Noebauer-Huhmann; Gregor Jost; Jan Endrikat; Siegfried Trattnig; Hubertus Pietsch
Journal:  Invest Radiol       Date:  2019-09       Impact factor: 6.016

5.  Shape-Dependent Relaxivity of Nanoparticle-Based T1 Magnetic Resonance Imaging Contrast Agents.

Authors:  Kayla S B Culver; Yu Jin Shin; Matthew W Rotz; Thomas J Meade; Mark C Hersam; Teri W Odom
Journal:  J Phys Chem C Nanomater Interfaces       Date:  2016-09-13       Impact factor: 4.126

Review 6.  MR imaging probes: design and applications.

Authors:  Eszter Boros; Eric M Gale; Peter Caravan
Journal:  Dalton Trans       Date:  2015-03-21       Impact factor: 4.390

7.  Probing the structure-relaxivity relationship of bis-hydrated Gd(DOTAla) derivatives.

Authors:  Eszter Boros; Peter Caravan
Journal:  Inorg Chem       Date:  2015-02-18       Impact factor: 5.165

8.  Biodegradable polydisulfide dendrimer nanoclusters as MRI contrast agents.

Authors:  Ching-Hui Huang; Kido Nwe; Ajlan Al Zaki; Martin W Brechbiel; Andrew Tsourkas
Journal:  ACS Nano       Date:  2012-10-29       Impact factor: 15.881

9.  Gd-labeled glycol chitosan as a pH-responsive magnetic resonance imaging agent for detecting acidic tumor microenvironments.

Authors:  Kido Nwe; Ching-Hui Huang; Andrew Tsourkas
Journal:  J Med Chem       Date:  2013-10-03       Impact factor: 7.446

Review 10.  Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers.

Authors:  Jessica Wahsner; Eric M Gale; Aurora Rodríguez-Rodríguez; Peter Caravan
Journal:  Chem Rev       Date:  2018-10-16       Impact factor: 60.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.